TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3588662

Group type: EXPERIMENTAL
Intervention: 0.6 mg bromocriptine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1.25 mg bromocriptine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2.5 mg bromocriptine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 25 mg imipramine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 50 mg imipramine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 29530107

Group type: EXPERIMENTAL
Intervention: Interpretation Bias Modification (IBM)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo Control (PC)
Number of subjects: 41
Study: 29267668

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 60
Study: 25935783

Group type: EXPERIMENTAL
Intervention: TrimoSan gel (applied vaginally twice weekly)
Number of subjects: 184

Group type: COMPARATOR
Intervention: No gel (standard pessary care)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: TrimoSan gel
Number of subjects: 184

Group type: COMPARATOR
Intervention: No gel
Number of subjects: 184
Study: 23370697

Group type: EXPERIMENTAL
Intervention: Exhalation during the lift
Number of subjects: 36

Group type: COMPARATOR
Intervention: Inhalation during the lift
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham (unconstrained coordination)
Number of subjects: 36
Study: 21226970

Group type: EXPERIMENTAL
Intervention: Collaborative Community Based Care (CCBC) + Facility Based Care (FBC)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Facility Based Care (FBC)
Number of subjects: 282
Study: 18071341

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet plus sibutramine (10 mg per day)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Hypocaloric diet only
Number of subjects: 59
Study: 16863011

Group type: EXPERIMENTAL
Intervention: Single-dose sertaconazole vaginal tablet (500 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional 3-dose econazole vaginal tablet (150 mg)
Number of subjects: 40
Study: 14681094

Group type: EXPERIMENTAL
Intervention: Deep hypothermia with circulatory arrest
Number of subjects: 20

Group type: COMPARATOR
Intervention: Deep hypothermia with low flow
Number of subjects: 20
Study: 10673309

Group type: COMPARATOR
Intervention: Interferon-alpha 2b alone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Interferon-alpha 2b plus 200 mg ketoprofen three times a week
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2b plus 200 mg ketoprofen twice a day
Number of subjects: 70
Study: 9487346

Group type: EXPERIMENTAL
Intervention: Salmeterol 25 micrograms
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Salmeterol 100 micrograms
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Salbutamol 100 micrograms
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Salbutamol 400 micrograms
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7648112

Group type: EXPERIMENTAL
Intervention: Low vacuum drainage
Number of subjects: 78

Group type: COMPARATOR
Intervention: High vacuum drainage
Number of subjects: 78
Study: 2719462

Group type: EXPERIMENTAL
Intervention: 750 mg of ciprofloxacin twice daily for 5 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 750 mg of ciprofloxacin twice daily for 10 to 14 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 750 mg of ciprofloxacin twice daily plus 300 mg of rifampin twice daily for 21 days
Number of subjects: 30
Study: 141237

Group type: EXPERIMENTAL
Intervention: d‐tubocurarine 0.4 mg/kg
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: alcuroium 0.3 mg/kg
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: gallamine 1.8 mg/kg
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: pancuronium
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: suxamethonium 0.8 mg/kg
Number of subjects: 400
Study: 31279278

Group type: EXPERIMENTAL
Intervention: High dosage (5g/100ml curry) - single meal
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: High dosage (5g/100ml curry) - multiple meals
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low dosage (1g/100ml curry) - single meal or multiple meals
Number of subjects: 6
Study: 28355706

Group type: EXPERIMENTAL
Intervention: Rock salt aerosol therapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Symptomatic treatment (control group)
Number of subjects: 65
Study: 26032440

Group type: EXPERIMENTAL
Intervention: Fish group (fatty fish consumption)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (meat, chicken, pork)
Number of subjects: 83
Study: 25091666

Group type: EXPERIMENTAL
Intervention: Three doses of Rotarix vaccine (n=45)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Five doses of Rotarix vaccine (n=45)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Vaccine responders
Number of subjects: 90
Study: 23068586

Group type: EXPERIMENTAL
Intervention: Electric blood-flow stimulator (VEINOPLUS)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Passive recovery
Number of subjects: 26
Study: 19411529

Group type: EXPERIMENTAL
Intervention: Survey respondents rating the importance of oral health
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: Survey respondents comparing oral health to diabetes
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: Survey respondents comparing oral health to heart disease
Number of subjects: 1636

Group type: EXPERIMENTAL
Intervention: Survey respondents comparing oral health to arthritis
Number of subjects: 1636
Study: 17208601

Group type: EXPERIMENTAL
Intervention: Probiotic treatment
Number of subjects: 1223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1223
Study: 15831783

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.25 mg (n = 12)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (n = 4)
Number of subjects: 16
Study: 11810416

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen (T‐E)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral estrogen (E)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral estrogen plus progestogen (E‐P)
Number of subjects: 50
Study: 9535437

Group type: EXPERIMENTAL
Intervention: Dilutional ultrafiltration during and modified ultrafiltration after cardiopulmonary bypass
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional ultrafiltration
Number of subjects: 24
Study: 9180950

Group type: EXPERIMENTAL
Intervention: 8OU of BoTox injected in four quadrants (1 ml in each quadrant‐20 U/ml) (n = 8)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normal saline solution as placebo injected in the same way (n = 5)
Number of subjects: 13
Study: 1827020

Group type: EXPERIMENTAL
Intervention: Isradipine (5 mg twice daily)
Number of subjects: 9
Study: 7325403

Group type: EXPERIMENTAL
Intervention: Buflomedil
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 31521613

Group type: EXPERIMENTAL
Intervention: CHMI-derived parasites from volunteer groups receiving different PfSPZ dose and route
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHMI-derived parasites
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-mosquito strain used for PfSPZ generation
Number of subjects: 0
Study: 28095505

Group type: EXPERIMENTAL
Intervention: Intensive 5-year home visiting parenting program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 25349264

Group type: EXPERIMENTAL
Intervention: Intratunnel femoral fixation with 2 bioabsorbable Rigidfix pins (cross‐pin fixation)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Extratunnel femoral fixation with 1 EndoButton cortical button per bundle
Number of subjects: 70
Study: 24148985

Group type: EXPERIMENTAL
Intervention: Beveled group (short bevel [45°, 1-2 mm long] prepared with a diamond bur)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-beveled group (control)
Number of subjects: 42
Study: 22832528

Group type: EXPERIMENTAL
Intervention: Sertraline (up to 150 mg per day)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 19455052

Group type: EXPERIMENTAL
Intervention: beta‐EPO
Number of subjects: 58
Study: 16769582

Group type: EXPERIMENTAL
Intervention: Pre‐emptive antithrombin III (ATIII) replacement therapy
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Combined high dose defibrotide (60 mg/day) and ATIII replacement therapy
Number of subjects: 162

Group type: COMPARATOR
Intervention: No specific VOD prophylaxis or therapy (Control)
Number of subjects: 162
Study: 15545790

Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Estrogen-progestin
Number of subjects: 1609

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1609
Study: 10929273

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg daily
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Olanzapine 5 mg daily
Number of subjects: 4

Group type: COMPARATOR
Intervention: Low-dose pimozide 2 mg daily
Number of subjects: 4

Group type: COMPARATOR
Intervention: Low-dose pimozide 4 mg daily
Number of subjects: 4
Study: 1632479

Group type: EXPERIMENTAL
Intervention: Pharmalgen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allpyral
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6465511

Group type: EXPERIMENTAL
Intervention: Urapidil (0.6 mg/kg before induction, 0.4 mg/kg +/- 0.2 mg/kg before termination)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 20
Study: 31432575

Group type: EXPERIMENTAL
Intervention: TRH followed by OST
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo followed by OST
Number of subjects: 26
Study: 30157940

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26803357

Group type: EXPERIMENTAL
Intervention: Intervention group (ecologic physical activity intervention)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Intervention group (girls)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Control group (girls)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Intervention group (boys)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Control group (boys)
Number of subjects: 379
Study: 25208756

Group type: EXPERIMENTAL
Intervention: Albiglutide (30 mg once a week, n=504)
Number of subjects: 779

Group type: COMPARATOR
Intervention: Insulin glargine (10 U once a day, n=241)
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Albiglutide
Number of subjects: 779

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 779
Study: 22703646

Group type: EXPERIMENTAL
Intervention: Super EBA
Number of subjects: 260

Group type: COMPARATOR
Intervention: MTA
Number of subjects: 260
Study: 20106567

Group type: EXPERIMENTAL
Intervention: Obeldicks light intervention (n=34; 6 months)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (n=32; no intervention for 6 months)
Number of subjects: 66
Study: 17868490

Group type: EXPERIMENTAL
Intervention: GOSPRO
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: PDXPRO
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: PRO
Number of subjects: 2
Study: 15986945

Group type: EXPERIMENTAL
Intervention: F2000 with F2000 self-etching primer/adhesive (F2000SE group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: F2000 with Single Bond (F2000SB group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Silux Plus with Single Bond (SiluxSB group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: F2000
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: F2000SE
Number of subjects: 90
Study: 12893713

Group type: EXPERIMENTAL
Intervention: Exercise (EX) group: 30 minutes of supervised exercise at 70% of target heart rate for five days of a seven-day period.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-exercise (NEX) group: No exercise intervention.
Number of subjects: 24
Study: 10402153

Group type: EXPERIMENTAL
Intervention: Alcohol cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control cues
Number of subjects: 0
Study: 9101901

Group type: EXPERIMENTAL
Intervention: Surgical treatment (early elective operations)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 46
Study: 1662796

Group type: EXPERIMENTAL
Intervention: M37 vaccine 10(4) PFU
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: M37 vaccine 10(5) PFU
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study: 4031977

Group type: EXPERIMENTAL
Intervention: Radiation therapy with BCNU
Number of subjects: 556

Group type: COMPARATOR
Intervention: Radiation therapy without BCNU
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Surgical excision for AAF
Number of subjects: 556

Group type: COMPARATOR
Intervention: Biopsy for AAF
Number of subjects: 556
Study: 31476161

Group type: EXPERIMENTAL
Intervention: Twendee X (TwX)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 29228101

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study: 27975350

Group type: EXPERIMENTAL
Intervention: Surgery (radiofrequency kyphoplasty, nucleotomy, spondylodesis)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: PainDetect questionnaire
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Oswestry Index questionnaire (ODI)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Patient satisfaction
Number of subjects: 139
Study: 25227830

Group type: EXPERIMENTAL
Intervention: Ten-minute brief physician counselling session to quit smoking
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (no counselling)
Number of subjects: 163
Study: 23762354

Group type: EXPERIMENTAL
Intervention: Gastric irrigation with 2 L saline solution before ESD
Number of subjects: 50

Group type: COMPARATOR
Intervention: No irrigation (regular group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Gastric irrigation with saline solution
Number of subjects: 50
Study: 21951354

Group type: EXPERIMENTAL
Intervention: PEDIATRIC PRO‐SELF©: Pain Control Program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interactive nursing support
Number of subjects: 0
Study: 19115593

Group type: EXPERIMENTAL
Intervention: 500 ml of HES 130/0.4 (Gr II : n = 61)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 1 liter of LR (Gr I: n = 59)
Number of subjects: 120
Study: 17000364

Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus (GDM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy pregnant women (control group)
Number of subjects: 26
Study: 14562117

Group type: EXPERIMENTAL
Intervention: interferon (IFN)‐alpha
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: chemotherapy (hydroxyurea (HU))
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: chemotherapy (busulfan)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: allografting
Number of subjects: 400
Study: 11211850

Group type: EXPERIMENTAL
Intervention: Evaluative speech task
Number of subjects: 115
Study: 8776909

Group type: EXPERIMENTAL
Intervention: Near patient test for CRP
Number of subjects: 181

Group type: COMPARATOR
Intervention: Beckman Array for CRP
Number of subjects: 181
Study: 1385618

Group type: EXPERIMENTAL
Intervention: Voluntary expectancies for stimulus changes or repetitions in random tone series (Experiment 1 and Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Voluntary expectancies for stimulus changes or repetitions in random tone series (Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled expectancy process (reflected mainly in RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Automatic expectancy process (reflected in P300 amplitude)
Number of subjects: 0
Study: 6340085

Group type: EXPERIMENTAL
Intervention: Meptazinol 100 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pentazocine 60 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pethidine 100 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Meptazinol 50-100 mg
Number of subjects: 120
Study: 30270489

Group type: EXPERIMENTAL
Intervention: PRISM intervention
Number of subjects: 92
Study: 29960105

Group type: EXPERIMENTAL
Intervention: Facilitated tucking combined with non-nutritive sucking
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-nutritive sucking alone
Number of subjects: 60
Study: 27583591

Group type: EXPERIMENTAL
Intervention: lopinavir concentrations <1 mg/L
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: lopinavir concentrations ≥1 mg/L
Number of subjects: 195

Group type: COMPARATOR
Intervention: nevirapine concentrations
Number of subjects: 195
Study: 25457928

Group type: EXPERIMENTAL
Intervention: Telephone cognitive-behavioral therapy (TCBT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard clinic-based face-to-face CBT
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both TCBT and face-to-face CBT
Number of subjects: 72
Study: 22395273

Group type: EXPERIMENTAL
Intervention: Unassisted PNF stretching with isometric contractions
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Unassisted PNF stretching with concentric contractions
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Unassisted PNF stretching with eccentric contractions
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Partner-assisted isometric PNF
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 13

Group type: COMPARATOR
Intervention: All stretching conditions
Number of subjects: 13
Study: 20133013

Group type: EXPERIMENTAL
Intervention: Imiquimod 2.5%
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Imiquimod 3.75%
Number of subjects: 479

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 479
Study: 18066136

Group type: EXPERIMENTAL
Intervention: Combination therapy (plant sterols + exercise)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Plant sterols
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control
Number of subjects: 84
Study: 15766371

Group type: EXPERIMENTAL
Intervention: Periodontal maintenance provided within the specialist clinic (Group A)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Periodontal maintenance provided by the referring general dentist (Group B)
Number of subjects: 35
Study: 12412822

Group type: COMPARATOR
Intervention: Zolmitriptan nasal spray (2.5, 5.0, or 10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zolmitriptan nasal spray (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zolmitriptan nasal spray (2.5 mg at pH 7.4, pH 5.0)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zolmitriptan (all formulations)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Zolmitriptan nasal spray vs oral formulations
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zolmitriptan nasal spray
Number of subjects: 12
Study: 10397477

Group type: EXPERIMENTAL
Intervention: Antioxidants (200 IU vitamin E, 9 mg beta-carotene, 500 mg vitamin C, 1.8 g red ginseng) for 4 weeks
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Red ginseng
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 8665710

Group type: EXPERIMENTAL
Intervention: Malleus-footplate assembly
Number of subjects: 34

Group type: COMPARATOR
Intervention: Tympanic membrane to footplate assembly
Number of subjects: 34
Study: 2225364

Group type: EXPERIMENTAL
Intervention: Intracoronary bolus of adenosine (16 micrograms)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intracoronary bolus of adenosine (12 micrograms)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of adenosine (80 micrograms/min or more)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of adenosine (140 micrograms/kg/min)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intracoronary boluses and intravenous infusions of adenosine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intracoronary bolus of adenosine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of adenosine (up to 240 micrograms/min)
Number of subjects: 58
Study: 494988

Group type: EXPERIMENTAL
Intervention: Immediate surgery (Group I, 18 patients)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Immediate surgery (Group II, 18 patients)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Antithyroid drugs (Group III, 34 patients)
Number of subjects: 70
Study: 31102008

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LAC)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Open surgery (OC)
Number of subjects: 66
Study: 28277801

Group type: EXPERIMENTAL
Intervention: Hib-MenAC vaccine
Number of subjects: 900

Group type: COMPARATOR
Intervention: Licensed Hib vaccine and MenAC vaccine
Number of subjects: 900
Study: 25760666

Group type: EXPERIMENTAL
Intervention: Telephonic MTM services provided by pharmacists
Number of subjects: 4
Study: 23244339

Group type: EXPERIMENTAL
Intervention: Glucose beverage (GI 100, GL 65)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Full milk beverage (GI 27, GL 5)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Half milk/glucose beverage (GI 84, GL 35)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (Glucose drink)
Number of subjects: 40
Study: 21314445

Group type: EXPERIMENTAL
Intervention: Acidform‐diaphragm
Number of subjects: 192

Group type: COMPARATOR
Intervention: HEC‐diaphragm
Number of subjects: 192

Group type: COMPARATOR
Intervention: Acidform only
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (HEC only)
Number of subjects: 192
Study: 19551682

Group type: EXPERIMENTAL
Intervention: Transpupillary thermotherapy (TTT)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Iodine‐125 brachytherapy (IBT)
Number of subjects: 95
Study: 17156477

Group type: EXPERIMENTAL
Intervention: Cilengitide (600 mg/m2 twice weekly for 4 weeks) and gemcitabine (1000 mg/m2 for 3 weeks followed by 1 week of rest)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Gemcitabine alone (1000 mg/m2 for 3 weeks followed by 1 week of rest)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Cilengitide and gemcitabine
Number of subjects: 89

Group type: COMPARATOR
Intervention: Gemcitabine alone
Number of subjects: 89